tradingkey.logo

GE Healthcare Technologies Inc

GEHC

68.090USD

+0.020+0.03%
收盤 04/29, 16:00美東報價延遲15分鐘
31.11B總市值
15.61本益比TTM

GE Healthcare Technologies Inc

68.090

+0.020+0.03%
關於 GE Healthcare Technologies Inc 公司
GE HealthCare Technologies Inc. 是一家醫療解決方案提供商,致力於創新醫療技術、藥物診斷以及集成的、基於雲的人工智能 (AI) 的解決方案、服務和數據分析。其業務部門包括成像、高級可視化解決方案 (AVS)、患者護理解決方案 (PCS) 和藥物診斷 (PDx)。其成像部門提供掃描設備、臨牀應用、服務功能和數字解決方案組合。其 AVS 部門提供超聲波、圖像引導治療和介入解決方案,產品組合涵蓋整個護理過程,包括某些疾病的篩查、診斷、治療和監測。其 PCS 部門包括患者監測、麻醉輸送和呼吸護理、診斷心臟病學、母嬰護理以及耗材和服務。其 PDx 部門開發和生產兩種類型的成像劑:造影劑和放射性藥物。
公司簡介
公司代碼GEHC
公司名稱GE Healthcare Technologies Inc
上市日期Dec 15, 2022
成立日期2022
CEOMr. Kevin Michael O'Neill
員工數量53000
證券類型Ordinary Share
年結日Dec 15
公司地址500 West Monroe Street
城市CHICAGO
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編60661
電話18337351139
網址https://www.gehealthcare.com
公司代碼GEHC
上市日期Dec 15, 2022
成立日期2022
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.15K
+160.52%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
66.05K
+1.93K%
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
31.67K
+19.01%
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
9.20K
--
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
8.76K
--
Dr. Rodney F. Hochman
Dr. Rodney F. Hochman
Independent Director
Independent Director
8.76K
--
Dr. Risa J. Lavizzo-Mourey, M.D.
Dr. Risa J. Lavizzo-Mourey, M.D.
Lead Independent Director
Lead Independent Director
7.07K
--
Dr. Tomislav Mihaljevic, M.D.
Dr. Tomislav Mihaljevic, M.D.
Independent Director
Independent Director
6.02K
--
Mr. Kevin Michael O'Neill
Mr. Kevin Michael O'Neill
Chief Executive Officer - Pharmaceutical Diagnostics
Chief Executive Officer - Pharmaceutical Diagnostics
165.00
-86.19%
Mr. Lloyd W. Howell, Jr.
Mr. Lloyd W. Howell, Jr.
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Peter J. Arduini
Mr. Peter J. Arduini
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.15K
+160.52%
Mr. Roland Rott
Mr. Roland Rott
President and CEO - Imaging
President and CEO - Imaging
66.05K
+1.93K%
Mr. Kenneth Robert (Ken) Stacherski
Mr. Kenneth Robert (Ken) Stacherski
Chief Global Supply Chain and Service Officer
Chief Global Supply Chain and Service Officer
31.67K
+19.01%
Mr. William J. Stromberg
Mr. William J. Stromberg
Independent Director
Independent Director
9.20K
--
Ms. Anne T. Madden
Ms. Anne T. Madden
Independent Director
Independent Director
8.76K
--
Dr. Rodney F. Hochman
Dr. Rodney F. Hochman
Independent Director
Independent Director
8.76K
--
收入明細
單位: USD更新時間: 4月6日 週日
單位: USD更新時間: 4月6日 週日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q1
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Total Imaging
8.86B
45.01%
Total Ultrasound
5.13B
26.08%
Total PCS
3.13B
15.89%
Total PDx
2.51B
12.75%
Other
52.00M
0.26%
地區USD
名稱
營收
佔比
Other
8.92B
45.34%
United States
8.62B
43.80%
China
2.13B
10.85%
業務
地區
業務USD
名稱
營收
佔比
Total Imaging
8.86B
45.01%
Total Ultrasound
5.13B
26.08%
Total PCS
3.13B
15.89%
Total PDx
2.51B
12.75%
Other
52.00M
0.26%
股東統計
更新時間: 2月21日 週五
更新時間: 2月21日 週五
持股股東
股東類型
持股股東
股東統計
佔比
Capital Research Global Investors
13.29%
The Vanguard Group, Inc.
11.43%
BlackRock Institutional Trust Company, N.A.
5.43%
State Street Global Advisors (US)
4.13%
Dodge & Cox
3.64%
Other
62.08%
持股股東
股東統計
佔比
Capital Research Global Investors
13.29%
The Vanguard Group, Inc.
11.43%
BlackRock Institutional Trust Company, N.A.
5.43%
State Street Global Advisors (US)
4.13%
Dodge & Cox
3.64%
Other
62.08%
股東類型
股東統計
佔比
Investment Advisor
40.35%
Investment Advisor/Hedge Fund
36.91%
Hedge Fund
3.13%
Research Firm
2.52%
Pension Fund
2.22%
Sovereign Wealth Fund
1.44%
Bank and Trust
1.32%
Insurance Company
0.36%
Individual Investor
0.27%
Other
11.47%
機構持股
更新時間: 1月19日 週日
更新時間: 1月19日 週日
報告期間
機構數
持股數
持股佔比
持股變動
2025Q1
2333
405.87M
88.75%
-9.18M
2024Q4
2344
405.16M
88.60%
-9.34M
2024Q3
2188
396.50M
86.79%
-11.03M
2024Q2
2081
391.61M
85.76%
-10.20M
2024Q1
2000
385.11M
84.39%
-2.29M
2023Q4
1855
385.99M
84.77%
-4.81M
2023Q3
1708
381.18M
83.73%
+1.51M
2023Q2
1574
374.50M
82.34%
-3.85M
2023Q1
1358
378.91M
83.35%
+182.70M
2022Q4
41
468.43M
103.20%
+468.43M
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Capital Research Global Investors
60.83M
13.3%
+2.61M
+4.48%
Dec 31, 2024
The Vanguard Group, Inc.
52.34M
11.45%
+2.16M
+4.30%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
24.86M
5.44%
+239.16K
+0.97%
Dec 31, 2024
State Street Global Advisors (US)
18.90M
4.13%
+281.45K
+1.51%
Dec 31, 2024
Dodge & Cox
16.68M
3.65%
+11.87K
+0.07%
Dec 31, 2024
Geode Capital Management, L.L.C.
11.32M
2.48%
+342.82K
+3.12%
Dec 31, 2024
Invesco Capital Management (QQQ Trust)
9.45M
2.07%
+126.88K
+1.36%
Feb 28, 2025
Norges Bank Investment Management (NBIM)
6.25M
1.37%
+1.84M
+41.76%
Dec 31, 2024
AllianceBernstein L.P.
6.13M
1.34%
-220.13K
-3.47%
Dec 31, 2024
Hotchkis and Wiley Capital Management, LLC
5.58M
1.22%
-18.35K
-0.33%
Dec 31, 2024
查看更多
持股ETF
更新時間: 4月6日 週日
更新時間: 4月6日 週日
機構名稱
佔比
Langar Global HealthTech ETF
10.47%
Invesco S&P Spin-Off ETF
7.54%
Otter Creek Focus Strategy ETF
4.86%
Absolute Select Value ETF
4.37%
iShares U.S. Medical Devices ETF
3.93%
Capital Group Dividend Value ETF
2.81%
VanEck Morningstar Wide Moat Value ETF
2.69%
VanEck Morningstar Wide Moat ETF
2.38%
VanEck Morningstar Wide Moat Growth ETF
1.99%
Themes US R&D Champions ETF
1.97%
查看更多
Langar Global HealthTech ETF
佔比10.47%
Invesco S&P Spin-Off ETF
佔比7.54%
Otter Creek Focus Strategy ETF
佔比4.86%
Absolute Select Value ETF
佔比4.37%
iShares U.S. Medical Devices ETF
佔比3.93%
Capital Group Dividend Value ETF
佔比2.81%
VanEck Morningstar Wide Moat Value ETF
佔比2.69%
VanEck Morningstar Wide Moat ETF
佔比2.38%
VanEck Morningstar Wide Moat Growth ETF
佔比1.99%
Themes US R&D Champions ETF
佔比1.97%
分紅派息
近5年累計派現 96.00M 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Nov 21, 2024
GEHC.NB Final Cash Dividend of gross USD 0.035 paid on Feb 14, 2025 going ex on Jan 14, 2025
Jan 14, 2025
Feb 14, 2025
Jan 14, 2025
Sep 18, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 15, 2024
Oct 18, 2024
Jun 26, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 15, 2024
Jul 19, 2024
Mar 22, 2024
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on May 15, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 15, 2024
Apr 18, 2024
Dec 08, 2023
GEHC.NB Final Cash Dividend of gross USD 0.03 paid on Feb 15, 2024 going ex on Jan 12, 2024
Jan 16, 2024
Feb 15, 2024
Jan 12, 2024
Sep 22, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Nov 15, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 15, 2023
Oct 19, 2023
Jun 23, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Aug 15, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Aug 15, 2023
Jul 20, 2023
Apr 25, 2023
GEHC.NB Interim Cash Dividend of gross USD 0.03 paid on Jun 15, 2023 going ex on May 22, 2023
May 23, 2023
Jun 15, 2023
May 22, 2023
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
tradingkey.logo
tradingkey.logo
日內數據由路孚特(Refinitiv)提供,並受使用條款約束。歷史及當前收盤數據均由路孚特提供。所有報價均以當地交易所時間為準。美股報價的即時最後成交數據僅反映透過納斯達克報告的交易。日內數據延遲至少15分鐘或遵循交易所要求。
* 參考、分析和交易策略由提供商Trading Central提供,觀點基於分析師的獨立評估和判斷,未考慮投資者的投資目標和財務狀況。
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有